Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/06/2009US20090197842 Therapeutic Agent for Neuropathic Pain
08/06/2009US20090197841 Inhalant Propellant-Free Aerosol Formulation
08/06/2009US20090197840 Composition and method for enhancing skin cell growth, proliferation and repair
08/06/2009US20090197839 Method of obtaining total fixed lipids from seeds of the sapodilla family, for the preparation of cosmetics and dermatological pharmaceutical compositions
08/06/2009US20090197837 Alendronate formulations, method of making and method of use thereof
08/06/2009US20090197836 Combination of FBPase Inhibitors and Antidiabetic Agents Useful for the Treatment of Diabetes
08/06/2009US20090197835 Vinyl phosphonate lysophosphatidic acid receptor antagonists
08/06/2009US20090197834 Quinolone derivative or pharmaceutically acceptable salt thereof
08/06/2009US20090197833 Silicon Containing Compounds Having Selective Cox-2 Inhibitory Activity and Methods of Making and Using the Same
08/06/2009US20090197832 Polymer mixtures of anionic and cationic polysaccharides and use thereof
08/06/2009US20090197831 Composition for the Treatment of Obesity and Hyperlipidemia
08/06/2009US20090197830 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia
08/06/2009US20090197829 Crosslinked polysaccharides and methods of production thereof
08/06/2009US20090197828 System, method and package for providing a sucrose solution
08/06/2009US20090197827 Combination Therapy for Treatment of FIV Infection
08/06/2009US20090197826 P-Toluene Sulfonic Acid Salt of 5-Amino-3-(2'-O-Acetyl-3'-Deoxy-Beta-D-Ribofuranosyl)-3H-Thiazole[4,5-d]pyrimidine-2-one and Methods for Preparation
08/06/2009US20090197825 Novel compounds and compositions and methods of use
08/06/2009US20090197824 Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
08/06/2009US20090197823 Aliskiren modulation of neurogenesis
08/06/2009US20090197822 Compositions and Methods for the Treatment of Chronic Infections
08/06/2009US20090197821 Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment
08/06/2009US20090197820 Compositions and Methods for Improving Cardiovascular Health
08/06/2009US20090197819 Compositions for improving and repairing skin
08/06/2009US20090197818 Use Of Ribose for Recovery From Anaesthesia
08/06/2009US20090197814 Chemically modified peptides derived from the chemokine CCL14 (HCC-1); replacement of the ultimate N-terminal amino acid of CCL14[9-74] by nonanoic acid (NNY) converts it into a potent agonist; inactivation of the chemokine receptor; antiinflammatory agents
08/06/2009US20090197813 Methods for treating FSH related conditions with GnRH antagonists
08/06/2009US20090197807 Sulphated hyaluronic acid for treating degenerative osteoarthritis
08/06/2009US20090197797 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents
08/06/2009US20090197796 Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors
08/06/2009US20090197795 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
08/06/2009US20090197794 Methods of Diagnosing and Treating an Inflammatory Response
08/06/2009US20090197315 Fullerene-based amino acids
08/06/2009US20090197276 Methods and compositions for predicting compliance with an antidepressant treatment regimen
08/06/2009US20090197268 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
08/06/2009US20090197267 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
08/06/2009US20090197266 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
08/06/2009US20090196940 Compositions and methods for supporting heat shock function
08/06/2009US20090196936 Hydrogel wound dressing and biomaterials formed in situ and their uses
08/06/2009US20090196935 Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets
08/06/2009US20090196933 Compositions and methods for preparation of poorly water soluble drugs with increased stability
08/06/2009US20090196932 Pharmaceutical compositions of atorvastatin
08/06/2009US20090196931 Therapeutic inhibitor of vascular smooth muscle cells
08/06/2009US20090196928 Biocompatible hydrogel compositions
08/06/2009US20090196924 Controlled-release lamotrigine formulations
08/06/2009US20090196922 Bilayer tablet for preventing cardiovascular events
08/06/2009US20090196920 Pharmaceutical composition comprising microcapsules of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa)
08/06/2009US20090196919 Oxcarbazepine dosage forms
08/06/2009US20090196918 Liposomal formulations of hydrophobic lactone drugs in the presence of metal ions
08/06/2009US20090196917 Liposomal Formulations of Hydrophobic Lactone Drugs in the Presence of Metal Ions
08/06/2009US20090196914 Liposomal l-carnitine
08/06/2009US20090196913 Anti-Alpha-V Immunoliposome Composition, Methods, and Uses
08/06/2009US20090196912 Pyridinylamines
08/06/2009US20090196910 Sustained-Release Preparation of Statin Drugs
08/06/2009US20090196907 Edible film-strips for immediate release of active ingredients
08/06/2009US20090196906 Kinase inhibitors
08/06/2009US20090196900 Use of Phosphodiesterase Inhibitor as a Component of Implantable Medical Devices
08/06/2009US20090196890 Pharmaceutical compositions
08/06/2009US20090196889 Controlled absorption of statins in the intestine
08/06/2009US20090196871 Use of 4-pyridylmethylphthalazines for cancer treatment
08/06/2009US20090196862 High dosage Vitamin D
08/06/2009US20090196861 Biocompatible Latent Emulsifiers
08/06/2009US20090196851 Use of Transcriptome Modifying Agents and Chemotherapy or Radiotherapy Against Cancer
08/06/2009US20090196848 Absorbent ingestible agents and associated methods of manufacture and use
08/06/2009US20090196847 Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof
08/06/2009US20090196844 Composition for inhibiting adhesion
08/06/2009US20090196839 Dispersion of polymer particles, composition comprising same and cosmetic treatment method
08/06/2009US20090196834 Tobacco alkaloid releasing chewing gum
08/06/2009US20090196833 Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome
08/06/2009US20090196824 Treatment of sequelae of psychiatric disorders
08/06/2009US20090194894 Residual solvent extraction method and microparticles produced thereby
08/06/2009DE102008007400A1 Substituierte Furane und ihre Verwendung Substituted furans and their use
08/06/2009DE102008006862A1 Use of sulfur in homeopathic agent and nutritional supplements for prophylaxis against infestations of ticks and fleas in humans and animals, where the nutritional supplements are useful as additive in animal food
08/06/2009DE102008006780A1 Verwendung von Tetrahydropyrimidinen Use of tetrahydropyrimidines
08/06/2009CA2751058A1 Corroles for neuroprotection and neurorescue
08/06/2009CA2728808A1 Pulmonary formulations of triptans
08/06/2009CA2715069A1 Novel heterocycles
08/06/2009CA2714160A1 A method of administering a pde3 inhibitor via titration for the treatment of peripheral arterial disease
08/06/2009CA2714008A1 2-amino quinoline derivatives useful as inhibitors of .beta.-secretase (bace)
08/06/2009CA2713998A1 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of.beta.-secretase (bace)
08/06/2009CA2713946A1 Adhesive patch
08/06/2009CA2713930A1 Combined use of angiogenesis inhibitor and taxane
08/06/2009CA2713808A1 Novel salts of o-desmethyl-venlafaxine
08/06/2009CA2713807A1 Compounds and compositions as kinase inhibitors
08/06/2009CA2713784A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs
08/06/2009CA2713780A1 Amino acid derivatives used as pharmaceutical substances
08/06/2009CA2713679A1 Orally rapidly disintegrating tablet comprising imidafenacin
08/06/2009CA2713677A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient
08/06/2009CA2713673A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
08/06/2009CA2713658A1 Oxim derivatives as hsp90 inhibitors
08/06/2009CA2713598A1 Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
08/06/2009CA2713571A1 Pharmaceutical composition or combination drug
08/06/2009CA2713553A1 Pyrazine derivatives and their use as protein kinase inhibitors
08/06/2009CA2713469A1 Methods and compositions relating to carcinoma stem cells
08/06/2009CA2713376A1 Use of hedgehog agonists in the treatment of musculoskeletal-related disorders
08/06/2009CA2713296A1 Method for determination of sensitivity to anti-cancer agent
08/06/2009CA2713293A1 Piperidine derivative
08/06/2009CA2713289A1 Substituted heteroarylamide diazepinopyrimidone derivatives
08/06/2009CA2713256A1 Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of gsk3-beta
08/06/2009CA2713253A1 Substituted arylamide oxazepinopyrimidone derivatives
08/06/2009CA2713248A1 Substituted heteroarylamide oxazepinopyrimidone derivatives
1 ... 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 ... 7860